Microbiome dysbiosis and its modulation in cancer development, prevention and therapy - Takeaways - MDSpire

Microbiome dysbiosis and its modulation in cancer development, prevention and therapy

  • By

  • Shivendra Dixit

  • Antonia Welker

  • Diego Ortiz

  • Marina Athanasouli

  • Christoph K. Stein-Thoeringer

  • July 2, 2026

  • 0 min

Share

  • 1

    Gut microbiome dysbiosis is linked to cancer development through mechanisms like chronic inflammation and immune defense disruption.

  • 2

    Microbiome-targeting strategies, including dietary modulation and probiotics, show promise in cancer prevention and treatment support.

  • 3

    Advances in microbial genomics and metabolomics aid in identifying biomarkers for predicting cancer risk and therapeutic outcomes.

  • 4

    Challenges in translating microbiome research into clinical oncology include interindividual variability and lack of standardized interventions.

  • 5

    Understanding the microbiome-cancer interface may lead to personalized, microbiome-informed oncology and precision-guided therapeutics.

Original Source(s)

Microbiome dysbiosis and its modulation in cancer development, prevention and therapy

  • by Shivendra Dixit, Antonia Welker, Diego Ortiz, Marina Athanasouli, Christoph K. Stein-Thoeringer

  • July 2, 2026

Related Content

Case report: Secretory carcinoma of the breast with ETV6-NTRK3 fusion: clinicopathological features and molecular confirmation by FISH in two cases

Multimodal imaging features of primary breast epithelial–myoepithelial carcinoma: a case report and literature review

Factors associated with relapse/progression in pediatric trunk and extremity rhabdomyosarcoma